Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 Oct;65(10):4043–4047. doi: 10.1128/iai.65.10.4043-4047.1997

Duration of immunity to reinfection with tick-transmitted Borrelia burgdorferi in naturally infected mice.

J Piesman 1, M C Dolan 1, C M Happ 1, B J Luft 1, S E Rooney 1, T N Mather 1, W T Golde 1
PMCID: PMC175581  PMID: 9317005

Abstract

The ability of naturally infected and cured mice to resist reinfection with tick-transmitted Borrelia burgdorferi was tested over a 1-year period. All of the mice were resistant to reinfection when they were challenged at 1.5 months after cure. The majority of animals were resistant to reinfection for up to 10.5 months after cure, but this resistance was lost at 1 year after cure. Both protected and unprotected animals showed a diverse array of antibodies on Western immunoblots. Protection was not associated with the killing of spirochetes in ticks, and naturally infected mice produced no antibodies to outer surface protein A (OSP A). The titers to whole Borrelia sonicate and OSP C, however, remained high throughout the 1-year study period. The levels of borreliacidal antibodies were highest in the 1.5 month-after-cure group. Natural immunity to reinfection with B. burgdorferi is limited in time, is complex, and may involve both humoral and cellular components.

Full Text

The Full Text of this article is available as a PDF (403.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alpert B., Esin J., Sivak S. L., Wormser G. P. Incidence and prevalence of Lyme disease in a suburban Westchester County community. N Y State J Med. 1992 Jan;92(1):5–8. [PubMed] [Google Scholar]
  2. Barthold S. W. Antigenic stability of Borrelia burgdorferi during chronic infections of immunocompetent mice. Infect Immun. 1993 Dec;61(12):4955–4961. doi: 10.1128/iai.61.12.4955-4961.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barthold S. W., Bockenstedt L. K. Passive immunizing activity of sera from mice infected with Borrelia burgdorferi. Infect Immun. 1993 Nov;61(11):4696–4702. doi: 10.1128/iai.61.11.4696-4702.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Burgdorfer W., Barbour A. G., Hayes S. F., Benach J. L., Grunwaldt E., Davis J. P. Lyme disease-a tick-borne spirochetosis? Science. 1982 Jun 18;216(4552):1317–1319. doi: 10.1126/science.7043737. [DOI] [PubMed] [Google Scholar]
  5. Callister S. M., Schell R. F., Case K. L., Lovrich S. D., Day S. P. Characterization of the borreliacidal antibody response to Borrelia burgdorferi in humans: a serodiagnostic test. J Infect Dis. 1993 Jan;167(1):158–164. doi: 10.1093/infdis/167.1.158. [DOI] [PubMed] [Google Scholar]
  6. Dunn J. J., Lade B. N., Barbour A. G. Outer surface protein A (OspA) from the Lyme disease spirochete, Borrelia burgdorferi: high level expression and purification of a soluble recombinant form of OspA. Protein Expr Purif. 1990 Nov;1(2):159–168. doi: 10.1016/1046-5928(90)90011-m. [DOI] [PubMed] [Google Scholar]
  7. Falco R. C., Fish D. Prevalence of Ixodes dammini near the homes of Lyme disease patients in Westchester County, New York. Am J Epidemiol. 1988 Apr;127(4):826–830. doi: 10.1093/oxfordjournals.aje.a114865. [DOI] [PubMed] [Google Scholar]
  8. Fikrig E., Telford S. R., 3rd, Barthold S. W., Kantor F. S., Spielman A., Flavell R. A. Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice. Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5418–5421. doi: 10.1073/pnas.89.12.5418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gern L., Schaible U. E., Simon M. M. Mode of inoculation of the Lyme disease agent Borrelia burgdorferi influences infection and immune responses in inbred strains of mice. J Infect Dis. 1993 Apr;167(4):971–975. doi: 10.1093/infdis/167.4.971. [DOI] [PubMed] [Google Scholar]
  10. Gilmore R. D., Jr, Kappel K. J., Dolan M. C., Burkot T. R., Johnson B. J. Outer surface protein C (OspC), but not P39, is a protective immunogen against a tick-transmitted Borrelia burgdorferi challenge: evidence for a conformational protective epitope in OspC. Infect Immun. 1996 Jun;64(6):2234–2239. doi: 10.1128/iai.64.6.2234-2239.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Golde W. T., Burkot T. R., Sviat S., Keen M. G., Mayer L. W., Johnson B. J., Piesman J. The major histocompatibility complex-restricted response of recombinant inbred strains of mice to natural tick transmission of Borrelia burgdorferi. J Exp Med. 1993 Jan 1;177(1):9–17. doi: 10.1084/jem.177.1.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hassler D., Maiwald M. Re-Infektionen mit Borrelia burgdorferi bei einem immunkompetenten Patienten. Dtsch Med Wochenschr. 1994 Mar 11;119(10):338–342. doi: 10.1055/s-2008-1058700. [DOI] [PubMed] [Google Scholar]
  13. Konishi T., Nakao M. Antibiotic treatment in mice infected with Japanese Borrelia garinii: efficacy of ceftriaxone for eradicating the infection induced by Ixodes persulcatus tick bites. Microbiol Immunol. 1997;41(2):165–168. doi: 10.1111/j.1348-0421.1997.tb01182.x. [DOI] [PubMed] [Google Scholar]
  14. Lane R. S., Piesman J., Burgdorfer W. Lyme borreliosis: relation of its causative agent to its vectors and hosts in North America and Europe. Annu Rev Entomol. 1991;36:587–609. doi: 10.1146/annurev.en.36.010191.003103. [DOI] [PubMed] [Google Scholar]
  15. Lastavica C. C., Wilson M. L., Berardi V. P., Spielman A., Deblinger R. D. Rapid emergence of a focal epidemic of Lyme disease in coastal Massachusetts. N Engl J Med. 1989 Jan 19;320(3):133–137. doi: 10.1056/NEJM198901193200301. [DOI] [PubMed] [Google Scholar]
  16. Maupin G. O., Fish D., Zultowsky J., Campos E. G., Piesman J. Landscape ecology of Lyme disease in a residential area of Westchester County, New York. Am J Epidemiol. 1991 Jun 1;133(11):1105–1113. doi: 10.1093/oxfordjournals.aje.a115823. [DOI] [PubMed] [Google Scholar]
  17. Pfister H. W., Neubert U., Wilske B., Preac-Mursic V., Einhäupl K. M., Borasio G. D. Reinfection with Borrelia burgdorferi. Lancet. 1986 Oct 25;2(8513):984–985. doi: 10.1016/s0140-6736(86)90640-9. [DOI] [PubMed] [Google Scholar]
  18. Piesman J., Mather T. N., Dammin G. J., Telford S. R., 3rd, Lastavica C. C., Spielman A. Seasonal variation of transmission risk of Lyme disease and human babesiosis. Am J Epidemiol. 1987 Dec;126(6):1187–1189. doi: 10.1093/oxfordjournals.aje.a114757. [DOI] [PubMed] [Google Scholar]
  19. Piesman J. Standard system for infecting ticks (Acari: Ixodidae) with the Lyme disease spirochete, Borrelia burgdorferi. J Med Entomol. 1993 Jan;30(1):199–203. doi: 10.1093/jmedent/30.1.199. [DOI] [PubMed] [Google Scholar]
  20. Roehrig J. T., Piesman J., Hunt A. R., Keen M. G., Happ C. M., Johnson B. J. The hamster immune response to tick-transmitted Borrelia burgdorferi differs from the response to needle-inoculated, cultured organisms. J Immunol. 1992 Dec 1;149(11):3648–3653. [PubMed] [Google Scholar]
  21. Rose C. D., Fawcett P. T., Klein J. D., Eppes S. C., Caputo G. M., Doughty R. A. Reinfection in paediatric Lyme borreliosis. Ann Rheum Dis. 1993 Sep;52(9):695–696. doi: 10.1136/ard.52.9.695-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Schaible U. E., Gern L., Wallich R., Kramer M. D., Prester M., Simon M. M. Distinct patterns of protective antibodies are generated against Borrelia burgdorferi in mice experimentally inoculated with high and low doses of antigen. Immunol Lett. 1993 May;36(2):219–226. doi: 10.1016/0165-2478(93)90056-8. [DOI] [PubMed] [Google Scholar]
  23. Schwan T. G., Piesman J., Golde W. T., Dolan M. C., Rosa P. A. Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2909–2913. doi: 10.1073/pnas.92.7.2909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Straubinger R. K., Summers B. A., Chang Y. F., Appel M. J. Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment. J Clin Microbiol. 1997 Jan;35(1):111–116. doi: 10.1128/jcm.35.1.111-116.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. de Silva A. M., Telford S. R., 3rd, Brunet L. R., Barthold S. W., Fikrig E. Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. J Exp Med. 1996 Jan 1;183(1):271–275. doi: 10.1084/jem.183.1.271. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES